MEMBERS of the Pharmaceutical Society of Australia (PSA) voted last night in support of the necessary constitutional changes to allow the acquisition of the Australasian College of Pharmacy (ACP) to goahead.
The decision to acquire the ACP, announced earlier this year (PD 29 Jan), is part of the PSA Board's broader strategic plan to grow value for members by expanding education opportunities for the profession, and securing a long-term, sustainable future for PSA as the premier training and education provider for pharmacists and pharmacy assistants.
Following the overwhelming support from members at the Special General Meeting last night, where 95% voted in favour of the proposed changes, the PSA is now working with ACP shareholders to undertake the necessary transaction and regulatory processes to enable theacquisition.
The move marks a significant milestone in PSA's journey to strengthening pharmacy education in Australia.
National President and Chair of the PSA Board, Associate Professor Fei Sim, welcomed the result, saying it reflects strong member support for PSA's vision for pharmacyeducation.
"Our members have shown us that they share our vision and our excitement for the future of pharmacy education, led by PSA," Assoc Prof Sim said.
"This is a vote of confidence in PSA's future, both as the premier pharmacy education provider and as the peak body for all pharmacists in all areas of practice.
"Our members are at the centre of everything we do, and we have heard them loud and clear.
"Tonight's voting outcome is one of the crucial steps," she continued.
"With this strategic direction endorsed by our members, we now progress to the next stage of the transaction and regulatoryprocesses.
"In navigating these next steps we are always acting in the best interests of our members to enable the successful acquisition.
"We are excited to start building the next chapter of PSA history, strengthening PSA's position in supporting and advocating for our members during this pivotal time of practice change," Assoc Prof Sim concluded. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 25
